Micro and Nanotechnology in Vaccine Development

Micro and Nanotechnology in Vaccine Development

Edited by Mariusz Skwarczynski, Vice-Chancellor and Fellow, University of Queensland, Australia and Istvan Toth, ARC Australian Professorial Fellow, Chair in Biological Chemistry, Professor of Pharmacy, Group Leader, IMB Division of Structural Biology   Features:

  • Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine development
  • Allows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their development
  • Includes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines

  • Table of Contents

    Overview of immune system.
    Innate immunity and special role of antigen presenting cells.
    Immunity and size.
    Introduction to the vaccines.
    Current challenges in vaccine development.
    Growing role of nanotechnology
    Nanotechnology in medical research
    Nanoparticle based peptide vaccines
    Liposome as nano- and microvaccines
    Lipid in peptide vaccine (excluding liposomes)
    Nanoadjuvants for peptide based vaccines
    Nanopatches for vaccine delivery
    Oral vaccine delivery
    Nano- and microtechnology in skin delivery of vaccines
    Nasal vaccine delivery
    Nanoparticles for cancer targeting vaccines by
    polymer based nanovaccines
    Lipidic microparticles for vaccine delivery
    Polymeric microparticles for vaccine delivery


    Description

    This book provides a comprehensive overview of how use of micro- and nanotechnology (MNT) has allowed major new advance in vaccine development research, and the challenges that immunologists face in making further progress.

    MNT allows the creation of particles that exploit the inherent ability of the human immune system to recognize small particles such as viruses and toxins. In combination with minimal protective epitope design, this permits the creation of immunogenic particles that stimulate a response against the targeted pathogen. The finely tuned response of the human immune system to small particles makes it unsurprising that many of the lead adjuvants and vaccine delivery systems currently under investigation are based on nanoparticles.

    Key Features

    • Provides a comprehensive and unparalleled overview of the role of micro- and nanotechnology in vaccine development
    • Allows researchers to quickly familiarize themselves with the broad spectrum of vaccines and how micro- and nanotechnologies are applied to their development
    • Includes a combination of overview chapters setting out general principles, and focused content dealing with specific vaccines, making it useful to readers from a variety of disciplines

    Readership

    Academic (researchers and grad students); Investigators in translational research; clinical scientists; pharmaceutical companies and development laboratories

Γράψτε μια αξιολόγηση

Σημείωση: η HTML δεν επεξεργάζεται!
    Κακή           Καλή

  • Συγγραφέας: Skwarczynski
  • Εκδότης: ELSEVIER
  • ISBN: 9780323399814
  • Σελίδες: 460
  • Έτος Έκδοσης: 2017
  • Διαστάσεις: 191 X 235 mm
  • Διαθεσιμότητα: Διαθέσιμο
  • 180,00€
  • 140,00€
  • Χωρίς ΦΠΑ: 132,08€

Ετικέτες: NANOTECHNOLOGY